DexCom EBITDA 2010-2024 | DXCM

DexCom annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • DexCom EBITDA for the quarter ending September 30, 2024 was $0.207B, a 18.29% decline year-over-year.
  • DexCom EBITDA for the twelve months ending September 30, 2024 was $0.840B, a 24.32% increase year-over-year.
  • DexCom 2023 annual EBITDA was $0.784B, a 43.25% increase from 2022.
  • DexCom 2022 annual EBITDA was $0.547B, a 48.75% increase from 2021.
  • DexCom 2021 annual EBITDA was $0.368B, a 0.33% increase from 2020.
DexCom Annual EBITDA
(Millions of US $)
2023 $784
2022 $547
2021 $368
2020 $367
2019 $191
2018 $-157
2017 $-26
2016 $-49
2015 $-46
2014 $-13
2013 $-21
2012 $-48
2011 $-40
2010 $-42
2009 $-42
DexCom Quarterly EBITDA
(Millions of US $)
2024-09-30 $207
2024-06-30 $210
2024-03-31 $154
2023-12-31 $269
2023-09-30 $254
2023-06-30 $172
2023-03-31 $89
2022-12-31 $162
2022-09-30 $187
2022-06-30 $121
2022-03-31 $78
2021-12-31 $33
2021-09-30 $144
2021-06-30 $125
2021-03-31 $67
2020-12-31 $124
2020-09-30 $113
2020-06-30 $83
2020-03-31 $47
2019-12-31 $116
2019-09-30 $69
2019-06-30 $11
2019-03-31 $-5
2018-12-31 $-156
2018-09-30 $22
2018-06-30 $2
2018-03-31 $-25
2017-12-31 $16
2017-09-30 $4
2017-06-30 $-10
2017-03-31 $-37
2016-12-31 $-3
2016-09-30 $-14
2016-06-30 $-16
2016-03-31 $-16
2015-12-31 $4
2015-09-30 $-40
2015-06-30 $-1
2015-03-31 $-10
2014-12-31 $4
2014-09-30 $-3
2014-06-30 $-4
2014-03-31 $-10
2013-12-31 $-0
2013-09-30 $-4
2013-06-30 $-8
2013-03-31 $-9
2012-12-31 $-6
2012-09-30 $-15
2012-06-30 $-13
2012-03-31 $-14
2011-12-31 $-11
2011-09-30 $-12
2011-06-30 $-6
2011-03-31 $-11
2010-12-31 $-9
2010-09-30 $-12
2010-06-30 $-10
2010-03-31 $-10
2009-12-31 $-9
2009-09-30 $-11
2009-06-30 $-12
2009-03-31 $-10
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $30.978B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.706B 24.73
Intuitive Surgical (ISRG) United States $193.352B 101.09
Alcon (ALC) Switzerland $43.519B 29.12
Edwards Lifesciences (EW) United States $41.599B 26.42
IQVIA Holdings (IQV) United States $36.625B 20.18
IDEXX Laboratories (IDXX) United States $35.273B 41.54
Waters (WAT) United States $22.985B 33.99
STERIS (STE) Ireland $21.603B 24.87
SONOVA HOLDING (SONVY) Switzerland $20.257B 0.00
Hologic (HOLX) United States $17.928B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.368B 13.72
Sysmex ADR (SSMXY) Japan $13.192B 41.37
Globus Medical (GMED) United States $11.424B 28.93
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.192B 44.48
Teleflex (TFX) United States $9.024B 14.39
Glaukos (GKOS) United States $7.669B 0.00
PROCEPT BioRobotics (PRCT) United States $5.015B 0.00
Integer Holdings (ITGR) United States $4.655B 26.38
Veracyte (VCYT) United States $3.419B 102.61
Inari Medical (NARI) United States $3.051B 0.00
TransMedics (TMDX) United States $2.857B 90.57
LivaNova (LIVN) United Kingdom $2.839B 16.39
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.209B 19.86
Tandem Diabetes Care (TNDM) United States $2.135B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.848B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Pulse Biosciences (PLSE) United States $1.284B 0.00
Artivion (AORT) United States $1.242B 82.28
OPKO Health (OPK) United States $1.044B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.901B 15.31
Paragon 28 (FNA) United States $0.864B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.738B 0.00
IRadimed (IRMD) United States $0.682B 36.87
Mesa Laboratories (MLAB) United States $0.660B 15.55
AxoGen (AXGN) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.561B 0.00
Treace Medical Concepts (TMCI) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Semler Scientific (SMLR) United States $0.503B 29.61
Tactile Systems Technology (TCMD) United States $0.446B 24.14
Delcath Systems (DCTH) United States $0.404B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.241B 0.00
Accuray (ARAY) United States $0.216B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.160B 0.00
Sensus Healthcare (SRTS) United States $0.140B 15.02
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.100B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.088B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Covalon Technologies (CVALF) Canada $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
Lucid Diagnostics (LUCD) United States $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00